Meta-analysis of patients in remission showed also higher levels of serum/plasma resistin in inactive IBD patients vs. healthy controls (IBD 0.60, 95% CI 0.15 to 2.57, p-value = 0.009, Fig. 5C). This evidence concerns the gene RETN and inflammatory bowel disease.